MedTrace Logo

Perioperative Continuous Glucose Monitoring Accuracy in Cardiac Surgery

NCT07385170 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-02-03

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate accuracy of continuous glucose monitoring device called 'Dexcom G7' in patients undergoing cardiac surgery.

Conditions

  • Cardiac Surgery

Interventions

DEVICE

Dexcom G7

Continuous glucose monitoring device (Dexcom G7) will be applied to patients undergoing cardiac surgery intraoperatively and postoperatively (maximum 10 days)

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-01
Primary Completion
2028-03-31
Completion
2028-04-30
FDA Device
Yes

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07385170 on ClinicalTrials.gov